A bone-mimicking nanocomposite made from self-assembling peptide nanofibers and ceramic nanoparticles passed all ISO 10993 biocompatibility tests and achieved complete bone regeneration in rabbits within one month.
Complete Bone Regeneration in 1 MonthThe peptide nanofiber-ceramic composite promoted full bone formation with blood vessel growth in rabbits while passing all international biocompatibility safety standards
What the researchers found
The peptide nanofiber-nanoceramic composite passed all ISO 10993 biocompatibility evaluations conducted by IFDA laboratories. Specific results included: non-cytotoxic with no significant reduction in cell viability, acceptable hemolytic activity in blood compatibility testing, no evidence of DNA damage in genotoxicity assays, no irritation or sensitization reactions, and no adverse clinical signs, weight changes, or organ pathologies in systemic toxicity studies in mice.
In the bone regeneration study in rabbits, the material demonstrated complete and osteoinductive bone formation over one month. The self-assembling peptide nanofibers (15-20 nm) contribute osteogenic, angiogenic, and immunomodulatory properties while mimicking extracellular matrix architecture. The spherical nanohydroxyapatite (30-45 nm) and tricalcium phosphate provide the mineral component with optimized particle size, morphology, and pH stability for vascularized bone formation.
Why it matters
Bone grafts are needed for millions of fractures, dental implants, and reconstructive surgeries annually, but no commercial product fully replicates bone's complex nanoscale structure. This peptide-ceramic composite is one of the first to pass comprehensive regulatory-grade safety testing while demonstrating actual bone regeneration capability. If it reaches clinical use, it could offer a superior alternative to current synthetic bone grafts.
How the study worked
The nanocomposite was evaluated following ISO 10993 international standards for biological evaluation of medical devices. Testing included in vitro assays (cytotoxicity, genotoxicity, hemocompatibility) and in vivo studies (sensitization and irritation in animal models, acute and chronic systemic toxicity in mice, and bone regeneration assessment in rabbits over one month). All biocompatibility testing was conducted by IFDA laboratories.
What this study cannot tell us
The bone regeneration study was conducted in rabbits over only one month, and long-term durability and remodeling were not assessed. Animal bone healing differs from human healing in speed and biology. The study does not report specific sample sizes for animal experiments. No comparison with commercially available bone graft materials was described. Human clinical trials would be needed before this material could be used in patients.
How to read the evidence
This is a preclinical study with in vitro and animal testing conducted to regulatory standards (ISO 10993). While the comprehensive safety battery and rabbit bone regeneration results are strong for this stage, this is still preclinical evidence — human clinical trials have not yet been conducted.
When this study was published
Published in 2025, this is very recent research representing the current state of the art in peptide-based biomaterials for bone regeneration. The regulatory-grade safety testing positions it for potential clinical translation.
The bigger picture
Self-assembling peptides are one of the most exciting frontiers in regenerative medicine. This study demonstrates that peptide nanofibers can be combined with bioceramics to create materials that not only mimic bone's architecture but also actively promote regeneration through osteogenic, angiogenic, and immunomodulatory activity. Successfully passing the full ISO 10993 safety battery is a critical milestone toward eventual clinical translation and regulatory approval.
Questions still open
- How does this peptide-ceramic nanocomposite perform compared to existing commercial bone graft products like demineralized bone matrix?
- What is the long-term fate of the peptide nanofibers — do they fully degrade and get replaced by natural bone tissue?
- How would this material perform in larger bone defects or in patients with compromised healing ability?
Common questions
What are self-assembling peptide nanofibers and how do they help bone heal?
Is this bone graft material safe for use in humans?
Read the original research
A meticulous biocompatibility and toxicological assessment of a self-assembling peptide nanofiber-nanoceramic biomimetic nanocomposite, per ISO 10993 guidelines.
Nanotoxicology, 19(5), 489-507
Citation
Chegeni, Solmaz; Tavakol, Hani; Rezayat, Seyed Mahdi; Tavakol, Shima. (2025). A meticulous biocompatibility and toxicological assessment of a self-assembling peptide nanofiber-nanoceramic biomimetic nanocomposite, per ISO 10993 guidelines.. Nanotoxicology, 19(5), 489-507. https://doi.org/10.1080/17435390.2025.2538479